Compounding pharmacies that set their own safety and accreditation standards now stand the best chance of keeping patient ...

Pharmaceutical Executive spoke with Michael Abrams, managing partner at global healthcare consultancy Numerof & Associates ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

FDA authorization is underpinned by four global Phase III QWINT studies showing non-inferior A1C lowering versus glargine ...

Jun Gong, MD, associate professor of medicine and medical director of colorectal cancer at Cedars-Sinai, spoke with ...

With healthcare costs dominating the conversation in recent years, the topic of employer-covered healthcare is a key issue.

The FDA's movement to encourage real-world data use through downstream acceptance is, in effect, a call to action for ...

Novo Nordisk secured Pharmashell access for up to five peptide programs, targeting long-acting injectable profiles and offering Nanexa >$1.33B total consideration plus low single-digit royalties.

As GLP-1 competition shifts from molecules to prescriptions, manufacturers, pharmacies, providers, and payers are racing to ...

PharmD, is Chief Compliance and Clinical Officer at Strive Pharmacy. With more than 10 years of pharmacy leadership experience and over four years at Strive, he oversees regulatory compliance, ...

Elaine Ferguson, global president at Inizio Medical, spoke with Pharmaceutical Executive about the importance of both managing and growing talent. In today’s world, this requires people already in ...

Chief executives from nine of Europe's largest drugmakers are calling on the European Union (EU) and its member states to ...